A Plus Asset Advisor Co Ltd (244920 KO) stock market data APIs
₩9272.3662
127.58(1.4%)
as of January 9, 2026
Try our APIs with
free plan!
A Plus Asset Advisor Co Ltd Financial Data Overview
Price chart is built with
Anychart
Aplus Asset Advisor Co. Ltd provides life and non-life insurance products. It also offers coverage analysis services; and comparative sales services of good insurance. In addition, the company provides health care services, such as health consultations with medical and nursing professionals, overseas medical emergency assistance services, dementia prevention solutions, and psychological counseling care services. Further, it offers funeral-related products and services. Additionally, the company provides financial planning and asset consulting services. Aplus Asset Advisor Co. Ltd was founded in 2007 and is headquartered in Seoul, South Korea.
Prev. Close
9272.3662
Open
9399.9486
High
9465.1934
Low
9044.4722
52 wk Range
3870-10130
Market Cap
208 443 M
Shares Outstanding
22 608 K
Revenue
648 368 M
EPS
214.0596
Beta
0.105
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get A Plus Asset Advisor Co Ltd data using free add-ons & libraries
Get A Plus Asset Advisor Co Ltd Fundamental Data
A Plus Asset Advisor Co Ltd Fundamental data includes:
- Net Revenue: 648 368 M
- EBITDA: 53 513 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-12
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
A Plus Asset Advisor Co Ltd News
New
Zai Lab Partner argenx Announces Positive Phase 3 Data from ADVANCE Trial of VYVGART® (efgartigimod alfa-fcab) in Adults with Primary Immune Thrombocytopenia
Zai Lab Limited - Study met primary endpoint, demonstrating a higher proportion of sustained platelet response with VYVGART treatment compared to placebo (p=0.0316); responders observed across patien...
KADESTONE CAPITAL CORP. REPORTS Q4 AND FULL YEAR 2021 FINANCIAL RESULTS
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, BC, Feb. 18, 2022 /CNW/ - Kadestone Capital Corp. ("Kadestone" or the "Company") (TSXV: KDSX) (OT...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
